eCite Digital Repository

Does prescribing of immediate release oxycodone by emergency medicine physicians result in persistence of Schedule 8 opioids following discharge?


Veal, F and Thompson, A and Halliday, S and Boyles, P and Orlikowski, C and Huckerby, E and Bereznicki, L, Does prescribing of immediate release oxycodone by emergency medicine physicians result in persistence of Schedule 8 opioids following discharge?, Emergency medicine Australasia pp. 1-5. ISSN 1742-6731 (2019) [Refereed Article]

Copyright Statement

Copyright 2019 Australasian College for Emergency Medicine

DOI: doi:10.1111/1742-6723.13442


Objectives: To identify the prevalence of oxycodone immediate release (IR) prescribed during an ED admission and the persistence of Schedule 8 (S8) opioids following an ED admission.

Methods: A retrospective cross‐sectional audit was undertaken reviewing all admission at the ED of the Royal Hobart Hospital, Tasmania, between 1 August and 30 September 2016. The admissions lists for ED were cross matched with the narcotic registers for oxycodone IR (the most commonly supplied S8 in ED) to identify how many patients received IR oxycodone during their ED admissions. Determination of the persistence of opioid use in opioid na´ve patients was then undertaken using the Tasmanian real time reporting database of all S8 opioid dispensed in Tasmania (DAPIS).

Results: There were 8432 ED admissions for 7065 patients aged over 13 years. IR oxycodone was prescribed during 1049 of these admissions (12.4%). Of the patients who were not taking regularly prescribed S8 opioids prior to their ED admission (n = 853), 48 patients (5.6%) were taking S8 opioids at both 2 and 6 months following their ED admission. Thirty patients (2.8%) were approved for authorities for long‐term opioids for non‐cancer pain.

Conclusion: These findings suggest that prescribing of IR oxycodone within ED is lower than previous studies. Additionally, the progression to regular chronic opioid use following an ED admission where IR oxycodone was given was relatively low with 3.0% of opioid na´ve patients being approved for indications related to chronic non‐cancer pain in the following 6 months.

Item Details

Item Type:Refereed Article
Keywords:emergency medicine, opioid, persistence, prescribing
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Clinical pharmacology and therapeutics
Objective Division:Health
Objective Group:Provision of health and support services
Objective Field:Nursing
UTAS Author:Veal, F (Ms Felicity Veal)
UTAS Author:Thompson, A (Mr Angus Thompson)
UTAS Author:Bereznicki, L (Professor Luke Bereznicki)
ID Code:136359
Year Published:2019
Deposited By:Pharmacy
Deposited On:2019-12-16
Last Modified:2020-05-13

Repository Staff Only: item control page